The pharmaceutical market in 2024 saw major shifts driven by obesity, diabetes, and oncology treatments. Leading products like Merck’s Keytruda and Novo Nordisk’s Ozempic continued to dominate, while new entrants such as Eli Lilly’s Mounjaro and Zepbound reshaped the market with unprecedented growth. Here’s a deep dive into the top 25 best-selling prescription drugs of…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
